Literature DB >> 17299723

Treatment with protease inhibitors and coinfection with hepatitis C virus are independent predictors of preterm delivery in HIV-infected pregnant women.

M Ravizza, P Martinelli, A Bucceri, S Fiore, S Alberico, E Tamburrini, C Tibaldi, G Guaraldi, G Anzidei, A Maccabruni, M P Crisalli, M Floridia.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17299723     DOI： 10.1086/507045

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  19 in total

1.  Antiretrovirals in pregnancy: a note of caution.

Authors:  D Heather Watts; Lynne M Mofenson
Journal:  J Infect Dis       Date:  2012-10-12       Impact factor: 5.226

2.  Comparative Safety of Antiretroviral Treatment Regimens in Pregnancy.

Authors:  Rebecca Zash; Denise L Jacobson; Modiegi Diseko; Gloria Mayondi; Mompati Mmalane; Max Essex; Chipo Petlo; Shahin Lockman; Joseph Makhema; Roger L Shapiro
Journal:  JAMA Pediatr       Date:  2017-10-02       Impact factor: 16.193

3.  Birth outcome in HIV vertically-exposed children in two Romanian centers.

Authors:  Ana Maria Tudor; Mariana Mărdărescu; Cristina Petre; Ruxandra Neagu Drăghicenoiu; Rodica Ungurianu; Cătălin Tilişcan; Dan Oţelea; Simona Claudia Cambrea; Doina Eugenia Tănase; Ana Maria Schweitzer; Simona Ruţă
Journal:  Germs       Date:  2015-12-02

4.  Prenatal protease inhibitor use and risk of preterm birth among HIV-infected women initiating antiretroviral drugs during pregnancy.

Authors:  Kunjal Patel; David E Shapiro; Susan B Brogly; Elizabeth G Livingston; Alice M Stek; Arlene D Bardeguez; Ruth E Tuomala
Journal:  J Infect Dis       Date:  2010-04-01       Impact factor: 5.226

5.  Low Prolactin and High 20-α-Hydroxysteroid Dehydrogenase Levels Contribute to Lower Progesterone Levels in HIV-Infected Pregnant Women Exposed to Protease Inhibitor-Based Combination Antiretroviral Therapy.

Authors:  Eszter Papp; Kayode Balogun; Nicole Banko; Hakimeh Mohammadi; Mona Loutfy; Mark H Yudin; Rajiv Shah; Jay MacGillivray; Kellie E Murphy; Sharon L Walmsley; Michael Silverman; Lena Serghides
Journal:  J Infect Dis       Date:  2016-01-05       Impact factor: 5.226

6.  Combination antiretroviral use and preterm birth.

Authors:  D Heather Watts; Paige L Williams; Deborah Kacanek; Raymond Griner; Kenneth Rich; Rohan Hazra; Lynne M Mofenson; Hermann A Mendez
Journal:  J Infect Dis       Date:  2012-11-29       Impact factor: 5.226

7.  Laboratory Abnormalities Among HIV-Exposed, Uninfected Infants: IMPAACT Protocol P1025.

Authors:  Jennifer S Read; Yanling Huo; Kunjal Patel; Marcia Mitchell; Gwendolyn B Scott
Journal:  J Pediatric Infect Dis Soc       Date:  2012-05-03       Impact factor: 3.164

8.  HCV-HIV coinfected pregnant women: data from a multicentre study in Italy.

Authors:  S Baroncelli; M F Pirillo; R Amici; E Tamburrini; O Genovese; M Ravizza; A Maccabruni; G Masuelli; G Guaraldi; G Liuzzi; C Pinnetti; V Giacomet; A Degli Antoni; A Vimercati; S Dalzero; V Sacchi; Marco Floridia
Journal:  Infection       Date:  2015-10-27       Impact factor: 3.553

9.  Protective Effect of Indoor Residual Spraying of Insecticide on Preterm Birth Among Pregnant Women With HIV Infection in Uganda: A Secondary Data Analysis.

Authors:  Michelle E Roh; Stephen Shiboski; Paul Natureeba; Abel Kakuru; Mary Muhindo; Teddy Ochieng; Albert Plenty; Catherine A Koss; Tamara D Clark; Patricia Awori; Miriam Nakalambe; Deborah Cohan; Prasanna Jagannathan; Roly Gosling; Diane V Havlir; Moses R Kamya; Grant Dorsey
Journal:  J Infect Dis       Date:  2017-12-19       Impact factor: 5.226

10.  Risk factors for preterm birth among HIV-infected pregnant Ugandan women randomized to lopinavir/ritonavir- or efavirenz-based antiretroviral therapy.

Authors:  Catherine A Koss; Paul Natureeba; Albert Plenty; Flavia Luwedde; Julia Mwesigwa; Veronica Ades; Edwin D Charlebois; Tamara D Clark; Jane Achan; Theodore Ruel; Bridget Nzarubara; Moses R Kamya; Diane V Havlir; Deborah Cohan
Journal:  J Acquir Immune Defic Syndr       Date:  2014-10-01       Impact factor: 3.731
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.